281 related articles for article (PubMed ID: 33737808)
1. Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy.
Zhao P; Qiu L; Zhou S; Li L; Qian Z; Zhang H
Int J Nanomedicine; 2021; 16():2107-2121. PubMed ID: 33737808
[TBL] [Abstract][Full Text] [Related]
2. Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy.
Xie W; Deng WW; Zan M; Rao L; Yu GT; Zhu DM; Wu WT; Chen B; Ji LW; Chen L; Liu K; Guo SS; Huang HM; Zhang WF; Zhao X; Yuan Y; Dong W; Sun ZJ; Liu W
ACS Nano; 2019 Mar; 13(3):2849-2857. PubMed ID: 30803232
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency.
Kong M; Tang J; Qiao Q; Wu T; Qi Y; Tan S; Gao X; Zhang Z
Theranostics; 2017; 7(13):3276-3292. PubMed ID: 28900509
[TBL] [Abstract][Full Text] [Related]
4. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
[TBL] [Abstract][Full Text] [Related]
5. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X
ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517
[TBL] [Abstract][Full Text] [Related]
7. Dual Modal Imaging-Guided Drug Delivery System for Combined Chemo-Photothermal Melanoma Therapy.
Zhang D; Zhang W; Wu X; Li Q; Mu Z; Sun F; Zhang M; Liu G; Hu L
Int J Nanomedicine; 2021; 16():3457-3472. PubMed ID: 34045853
[TBL] [Abstract][Full Text] [Related]
8. Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma.
Zhang N; Song J; Liu Y; Liu M; Zhang L; Sheng D; Deng L; Yi H; Wu M; Zheng Y; Wang Z; Yang Z
J Control Release; 2019 Jul; 306():15-28. PubMed ID: 31132380
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
10. Dacarbazine-Loaded Hollow Mesoporous Silica Nanoparticles Grafted with Folic Acid for Enhancing Antimetastatic Melanoma Response.
Liu Q; Xu N; Liu L; Li J; Zhang Y; Shen C; Shezad K; Zhang L; Zhu J; Tao J
ACS Appl Mater Interfaces; 2017 Jul; 9(26):21673-21687. PubMed ID: 28590113
[TBL] [Abstract][Full Text] [Related]
11. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
12. PEGylated polyaminoacid-capped mesoporous silica nanoparticles for mitochondria-targeted delivery of celastrol in solid tumors.
Choi JY; Gupta B; Ramasamy T; Jeong JH; Jin SG; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 May; 165():56-66. PubMed ID: 29453086
[TBL] [Abstract][Full Text] [Related]
13. Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies.
Drača D; Edeler D; Saoud M; Dojčinović B; Dunđerović D; Đmura G; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2021 Apr; 217():111383. PubMed ID: 33582397
[TBL] [Abstract][Full Text] [Related]
14. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity.
Ding B; Wu X; Fan W; Wu Z; Gao J; Zhang W; Ma L; Xiang W; Zhu Q; Liu J; Ding X; Gao S
Int J Nanomedicine; 2011; 6():1991-2005. PubMed ID: 21976975
[TBL] [Abstract][Full Text] [Related]
15. PD-1 blockade combined with IL-33 enhances the antitumor immune response in a type-1 lymphocyte-mediated manner.
He H; Shi L; Meng D; Zhou H; Ma J; Wu Y; Wu Y; Gu Y; Xie W; Zhang J; Zhu Y
Cancer Treat Res Commun; 2021; 28():100379. PubMed ID: 33951555
[TBL] [Abstract][Full Text] [Related]
16. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
17. Polydopamine-Mesoporous Silica Core-Shell Nanoparticles for Combined Photothermal Immunotherapy.
Seth A; Gholami Derami H; Gupta P; Wang Z; Rathi P; Gupta R; Cao T; Morrissey JJ; Singamaneni S
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42499-42510. PubMed ID: 32838525
[TBL] [Abstract][Full Text] [Related]
18. Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.
Iannone R; Miele L; Maiolino P; Pinto A; Morello S
Neoplasia; 2013 Dec; 15(12):1400-9. PubMed ID: 24403862
[TBL] [Abstract][Full Text] [Related]
19. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
[TBL] [Abstract][Full Text] [Related]
20. Bacterial Vesicle-Cancer Cell Hybrid Membrane-Coated Nanoparticles for Tumor Specific Immune Activation and Photothermal Therapy.
Wang D; Liu C; You S; Zhang K; Li M; Cao Y; Wang C; Dong H; Zhang X
ACS Appl Mater Interfaces; 2020 Sep; 12(37):41138-41147. PubMed ID: 32830477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
